SAN FRANCISCO and VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the “Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to begin mid ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to begin mid ...

Q4 2025 earnings call recap: loan/deposit growth, NIM outlook amid rate cuts, funding costs, buybacks, and 2026 risks—read ...

Before we begin, I'd like to remind you that the comments made during the call include forward-looking statements as defined ...

Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

Q1 2026 earnings call recap: sales and margin growth, unchanged guidance, AIS/ABL updates, backlog and tariff risks—read key ...

When everyone trusts the numbers and speaks the same analytical language, finance empowers the organization to make faster, ...

Pick the sources you trust and let NotebookLM craft clear summaries with citations, so meetings and presentations come ...

I’m often asked the exact moment when someone can finally declare, with confidence (and maybe a dramatic pause), that they’ve achieved Kaizen mastery.